LLY
Stock Details
LLY is Eli Lilly and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 336.00$. Average daily volumn in 3 months 3.06M. Market cap 314.46B
Stock symbol : LLY. Exchange : NYSE. Currency : USD Lastest price : 329.84$. Total volume : 575.38k. Market state REGULAR Click reload if you want to check the lastest price on market!!!
Eli Lilly and Company (LLY)
Last Price
329.84$Change
-3.76Volume
575.38k
| Previous Close | 333.60 |
| Open | 334.39 |
| Day Range | 329.60-334.61 |
| Bid | 330.31 x 900 |
| Ask | 330.56 x 1k |
| Volume | 575.38k |
| Average Volume | 3.06M |
| Market Cap | 314.46B |
| Beta | 0.35 |
| 52 Week Range | 276.83-375.25 |
| Trailing P/E | 47.73 |
| Foward P/E | 28.17 |
| Dividend (Yield %) | 1.37% |
| Ex-Dividend Date | 2023-02-14 |
Financial Details
Organization
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramz... a for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Market Cap:
314.46BRevenue:
28.54BTotal Assets:
49.49BTotal Cash:
2.07B
News about "Eli Lilly and Company"
Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock
Source from : YAHOO!Finance - 9 hours ago
Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...See details»
Estimating The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY)
Source from : YAHOO!Finance - 3 days ago
With US$329 share price, Eli Lilly appears to be trading close to its estimated fair value Our fair value estimate is 3.4% lower than Eli Lilly's analyst price target of US$375 How far off is Eli ...See details»
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Source from : MSN - 14 days ago
Eli Lilly (LLY) is one of the stocks most watched ... Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead ...See details»
Eli Lilly & Co. stock rises Wednesday, outperforms market
Source from : MarketWatch - 6 days ago
Shares of Eli Lilly & Co. inched 0.73% higher to $329.47 Wednesday, on what proved to be an all-around grim trading session for the stock market, with ...See details»
Eli Lilly and Company (NYSE:LLY) Looks Interesting, And It's About To Pay A Dividend
Source from : Yahoo - 1 month ago
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Eli Lilly and Company (NYSE:LLY) is about to trade ex-dividend in the next four days.See details»
SEC rejects Eli Lilly's request to exclude DEI shareholder proposal
Source from : Pensions&Investments - 6 days ago
SEC officials have denied Eli Lilly's request to exclude a shareholder proposal seeking DEI data from the pharmaceutical company.See details»
Eli Lilly and Company
Source from : Entrepreneur - 20 days ago
Eli Lilly and Company, one of three companies in the U.S. that produce insulin, said it would slash the price of its insulin products after years of calls for it to do so. We'll be in your inbox ...See details»
Eli Lilly to cut insulin prices up to 70% amid federal pressure to lower costs
Source from : USA Today - 20 days ago
Eli Lilly and Co. said it will cut prices of its ... prices by 70% for the fast-acting injectable Humalog, which is the company's most commonly prescribed insulin. Lilly also will discount ...See details»
Eli Lilly and Company (LLY) Presents at Cowen's 43rd Annual Health Care Conference (Transcript)
Source from : Seeking Alpha - 14 days ago
[Call Starts Abruptly] at the Cowen Conference again this year. Representing the company is Mike Mason, who is President of Lilly Diabetes. So Mike, thank you for making the journey. Lots to cover ...See details»
Eli Lilly cannot exclude DEI proposal requested by shareholders from proxy statement, SEC says
Source from : HR Dive - 6 days ago
The request “transcends ordinary business matters because it raises human capital management issues with a broad societal impact,” the SEC said.See details»
Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
Source from : Benzinga.com - 20 days ago
INDIANAPOLIS, March 1, 2023 /PRNewswire/ -- Eli Lilly and Company LLY today announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value ...See details»
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Axsome Therapeutics (AXSM)
Source from : Business Insider - 8 days ago
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eli Lilly & Co (LLY – Research Report) and Axsome Therapeutics (AXSM – Research Report).See details»
Eli Lilly forays into dermatological space with launch of psoriasis drug
Source from : devdiscourse - 7 days ago
Drug firm Eli Lilly on Tuesday said it has forayed into the dermatological space in the country with the launch of a product to treat moderate-to-severe plaque psoriasis.The company has launched ...See details»
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Source from : Nasdaq - 27 days ago
Eli Lilly (LLY) has recently been on ... While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate ...See details»